Skip to main content

Advertisement

Log in

Independent from muscle power and balance performance, a creatinine clearance below 65 ml/min is a significant and independent risk factor for falls and fall-related fractures in elderly men and women diagnosed with osteoporosis

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Summary

We assessed in a cross-sectional study in elderly men and women with osteoporosis, the association between the creatinine clearance (CrCl) and the performance in different balance and muscle power and function tests and found that a decreasing creatinine clearance was significantly associated with lower balance and muscle power.

Introduction

To determine if a creatinine clearance of <65 ml/min is significantly associated with decreasing muscle power and balance and an increased risk for falls and fractures.

Methods

We assessed in a cross-sectional-study in 1781 German osteoporotic patients, the association between the CrCl, the physical performance, and the number of falls and fractures.

Results

Controlling for age, gender, BMI, and osteoporosis treatment (fracture analysis only), a decreasing CrCl was associated with lower physical performance in the timed-up-and-go test (corr −0.2337, P < 0.0001), chair-rising test (corr −0.1706, P < 0.001), and tandem-stand test (corr 0.2193, P < 0.0001), and a CrCl of <65 ml/min was associated with a significantly higher risk for falls (47.7% vs. 36.2%, P = 0.0008) and fall-related fractures (33.1% vs. 22.9%, P = 0.0003) compared with a CrCl of ≥65 ml/min.

Conclusions

In this study, we found a significant gender-independent correlation between decreasing CrCl and lower performance in balance and muscle power tests. Reduced muscle power and balance may therefore be involved in the low creatinine clearance associated increased risk for falls and fall-related fractures. Furthermore, we found that a CrCl <65 ml/min., independent from the performance in muscle power, muscle function, and balance tests, is a significant risk factor for falls and fractures.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Tinetti ME, Inouye SK, Gill TM et al (1995) Shared risk factors for falls, incontinence, and functional dependence. Unifying the approach to geriatric syndromes. JAMA 273(17):1348–1353

    Article  CAS  PubMed  Google Scholar 

  2. Bischoff HA, Stähelin HB, Urscheler N et al (1999) Muscle strength in the elderly: its relation to vitamin D metabolites. Arch Phys Med Rehabil 80(1):54–58

    Article  CAS  PubMed  Google Scholar 

  3. Pfeifer M, Begerow B, Minne HW et al (2000) Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women. J Bone Miner Res 15(6):1113–1118

    Article  CAS  PubMed  Google Scholar 

  4. Dukas L, Staehelin HB, Schacht E, Bischoff HA (2005) Better functional mobility in community-dwelling elderly is related to d-hormone serum levels and a to a daily calcium intake. Nutr Health Aging 9(5):347–351

    CAS  Google Scholar 

  5. Bischoff HA, Stähelin HB, Dick W et al (2003) Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res 18:343–351

    Article  CAS  PubMed  Google Scholar 

  6. Gallagher JC (2004) The effects of calcitriol on falls and fractures and physical performance tests. J Steroid Biochem Mol Biol 89–90:497–501

    Article  PubMed  CAS  Google Scholar 

  7. Dukas L, Bischoff HA, Lindpaintner LS, Schacht E, Birkner-Binder D, Damm T, Thalmann B, Stähelin HB (2004) Alfacalcidol reduces the number of fallers in a community-dwelling elderly population with a minimum calcium intake of 500 mg daily. J Am Geriatr Soc 52:1–7

    Article  Google Scholar 

  8. Faulkner KA, Cauley JA, Zmuda JM, Landsittel DP, Newman AB, Studenski SA, Redfern MS, Ensrud KE, Fink HA, Lane NE, Nevitt MC (2006) Higher 1,25-dihydroxyvitamin D3 concentrations associated with lower fall rates in older community-dwelling women. Osteoporos Int 17(9):1318–1328

    Article  CAS  PubMed  Google Scholar 

  9. Boland R (1986) Role of vitamin D in skeletal muscle function. Endocr Rev 7:434–447

    Article  CAS  PubMed  Google Scholar 

  10. Sorensen OH, Lund BI, Saltin B et al (1979) Myopathy in bone loss of aging: improvement by treatment with 1 alpha-hydroxycholecalciferol and calcium. Clin Sci 56(2):157–161

    CAS  PubMed  Google Scholar 

  11. Endo I, Inoue D, Mitsui T, Umaki Y, Akaike M, Yoshizawa T, Kato S, Matsumoto T (2003) Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. Endocrinology 144(12):5138–5144

    Article  CAS  PubMed  Google Scholar 

  12. Dukas L, Schacht E, Stahelin HB (2005) In elderly men and women treated for osteoporosis a low creatinine clearance of <65 ml/min is a risk factor for falls and fractures. Osteoporos Int 16(12):1683–1690

    Article  CAS  PubMed  Google Scholar 

  13. Dukas LC, Schacht E, Mazor Z, Stahelin HB (2005) A new significant and independent risk factor for falls in elderly men and women: a low creatinine clearance of less than 65 ml/min. Osteoporos Int 16(3):332–338

    Article  CAS  PubMed  Google Scholar 

  14. Dukas L, Schacht E, Mazor Z, Stahelin HB (2005) Treatment with alfacalcidol in elderly people significantly decreases the high risk of falls associated with a low creatinine clearance of <65 ml/min. Osteoporos Int 16(2):198–203

    Article  CAS  PubMed  Google Scholar 

  15. Gallagher JC, Rapuri PB, Smith LM (2007) An age related decrease in creatinine clearance is associated with an increase in number of falls in untreated women but not in women receiving calcitriol. J Clin Endocrinol Metab 92:51–58

    Article  CAS  PubMed  Google Scholar 

  16. Ensrud KE, Lui L-Y, Taylor BC, Ishani A, Shlipak MG, Stone KL, Cauley JA, Jamal SA, Antoniucci DM, Cummings SR, for the Study of Osteoporotic Fractures Research Group (2007) Renal function and risk of hip and vertebral fractures in older women. Arch Intern Med 167:133–139

    Article  PubMed  Google Scholar 

  17. Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16(1):31–41

    Article  CAS  PubMed  Google Scholar 

  18. Podsialdo D, Richardson S (1991) The timed "Up & Go": a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 39(2):142–148

    Google Scholar 

  19. Mathias S, Nayak US, Isaacs B (1986) Balance in elderly patients: the "get-up and go" test. Arch Phys Med Rehabil 67(6):387–389

    CAS  PubMed  Google Scholar 

  20. Zhu K, Devine A, Prince RL (2008) Timed Up and Go Test and BMD as predictors of fractures: a 10-year longitudinal study. J Bone Min Res 23:s119

    Google Scholar 

  21. Guralnik JM, Ferrucci L, Simonsick EM, Salive ME, Wallace RB (1995) Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Eng J Med 332:556–561

    Article  CAS  Google Scholar 

  22. Gill TM, Williams CS, Tinetti ME (1995) Assessing risk for the onset of functional dependence among older adults: the role of physical performance. J Am Geriatr Soc 43:603–609

    CAS  PubMed  Google Scholar 

  23. Runge M, Rehfeld G, Resnicek E (2000) Balance training and exercise in geriatric patients. J Musculoskel Neuronal Interact 1:54–58

    Google Scholar 

  24. Winer BJ (1971) Statistical principles in experimental design, 2nd edn. McGraw Hill, New York, p 514

    Google Scholar 

  25. Skeleton DA, Greig CA, Davies JM (1994) Strength, power and related functional ability of healthy people aged 65–89 years. Age Ageing 23:371–377

    Article  Google Scholar 

  26. Danneskiold-Samsǿe B, Kofod V, Munter J (1984) Muscle strength and functional capacity in 78–81 year old men and women. Eur J Appl Physiol 52:310–314

    Article  Google Scholar 

  27. McMurdo ME (1997) Physical activity and health in old age. Scott Med J 42(5):154–155

    CAS  PubMed  Google Scholar 

  28. Rejeski WJ, Mihalko SL (2001) Physical activity and quality of life in older adults. J Gerontol A Biol Sci Med Sci 56:23–35 Spec No 2(2)

    PubMed  Google Scholar 

  29. Lee MS, Tanaka K (1997) Significance of health fitness appraisal in an aging society. Appl Human Sci 16(4):123–131

    Article  CAS  PubMed  Google Scholar 

  30. Schacht E (1999) Rationale for treatment of involutional osteoporosis in women and for prevention and treatment of corticosteroid-induced osteoporosis with alfacalcidol. Calcif Tissue Int 65:317–327

    Article  CAS  PubMed  Google Scholar 

  31. Lau KHW, Baylink DJ (1999) Vitamin D therapy of osteoporosis: plain vitamin D therapy versus active vitamin D analog (d-hormone) therapy. Calcif Tissue Int 65:295–306

    Article  CAS  PubMed  Google Scholar 

  32. Richy F, Deroisy R, Lecart M-P, Hanssens L, Mawet A, Reginster J-Y (2005) D-hormone analog alfacalcidol: an update on its role in post-menopausal osteoporosis and rheumatoid arthritis management. Aging Clin Exp Res 17:133–142

    CAS  PubMed  Google Scholar 

  33. Schacht E, Richy F, Reginster J-Y (2005) The therapeutic effects of alfacalcidol on bone strength, muscle metabolism and prevention of falls and fractures. J Musculoskelet Neuronal Interact 5:273–284

    CAS  PubMed  Google Scholar 

  34. Tinetti ME, Williams CS (1998) The effect of falls and fall injuries on functioning in community-dwelling older persons. J Gerontol A Biol Sci Med Sci 53(2):M112–M119

    CAS  PubMed  Google Scholar 

  35. Stein MS, Wark JD, Scherer SC, Walton SL, Chick P, Di Carlantonio M, Zajac JD, Flicker L (1999) Falls related to vitamin D and parathyroid hormone in Australian nursing home and hostel. J Am Ger Soc 47:1195–1201

    CAS  Google Scholar 

  36. Klawansky S, Komaroff E, Cavanaugh PF, Mitchell DY, Gordon MJ, Connelly JE, Ross SD (2003) The relationship between age, renal function and bone mineral density in the US population. Osteoporos Int 14:570–576

    Article  CAS  PubMed  Google Scholar 

  37. Jassal SK, von Muhlen D, Barrett-Connor E (2007) Measures of renal function, BMD, bone loss, and osteoporotic fracture in older adults: the Rancho Bernardo study. J Bone Miner Res 22:203–210

    Article  CAS  PubMed  Google Scholar 

  38. Trombetti A, Stoermann-Chopard C, Ferrari S, Saudan P, Chevalley T, Binet I, Uebelhart B, Rizzoli R, Martin PY (2003) Prävention von Knochenkomplikationen bei Patienten mit chronischer Niereninsuffizienz (1.Teil). Swiss Med Forum 11:260–266

    Google Scholar 

  39. Slovik DM, Adams JS, Neer RM et al (1981) Deficient production of 1,25-dihydroxyvitamin D in elderly osteoporotic patients. N Engl J Med 305:372–374

    Article  CAS  PubMed  Google Scholar 

  40. Oelzner P, Muller A, Deschner F, Huller M, Abendroth K, Hein G et al (1998) Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Calcif Tissue Int 62:193–198

    Article  CAS  PubMed  Google Scholar 

  41. Epstein S, Bryce G, Hinman JW et al (1986) The influence of age on bone mineral regulating hormones. Bone 7:421–425

    Article  CAS  PubMed  Google Scholar 

  42. Tsai KS, Heath H III, Kumar R et al (1984) Impaired vitamin D metabolism with aging in women: possible role in pathogenesis of senile osteoporosis. J Clin Invest 73:1668–1672

    Article  CAS  PubMed  Google Scholar 

  43. Dukas L, Bischoff HA, Schacht E et al (2002) Normal 25(OH) vitamin D serum levels do not exclude d-hormone deficiency in community-dwelling elderly. Osteoporos Int 13(1):S35

    Google Scholar 

  44. Peacock M, Heyburn P (1977) Effect of vitamin D3 metabolites on proximal muscle weakness. Calcif Tiss Res 24(Suppl):R20–R23

    Google Scholar 

  45. Verhaar HJJ, Samson MM, Jansen PAF et al (2000) Muscle strength, functional mobility and vitamin D in older women. Aging Clin Exp Res 12:455–460

    CAS  Google Scholar 

  46. Dhesi JK, Bearne LM, Monitz C, Hurley MV, Jackson SHD, Swift CG, Allain TJ (2002) Neuromuscular and psychomotor function in elderly subjects who fall and the relationship with vitamin D status. J Bone Miner Res 17:891–897

    Article  CAS  PubMed  Google Scholar 

  47. Koike T, Okawa T, Wada M, Kita T, Takaoka K (2003) Effects of a long-term alfacalcidol or calcitonin administration on body sway in Japanese elderly women. J Bone Miner Res 18(S2)):S168

    Google Scholar 

  48. Gryfe CI, Amies A, Ashley MJ (1997) A longitudinal study of falls in an elderly population: incidence and morbidity. Age Aeing 6(4):201–210

    Article  Google Scholar 

  49. Liu S, Tang W, Zhou J et al (2006) Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D. J Am Soc Nephrol 17:1305–1315

    Article  CAS  PubMed  Google Scholar 

  50. Cappola AR, Xue QL, Ferrucci L, Guralnik JM, Volpato S, Fried LP (2003) Insulin-like growth factor I and interleukin-6 contribute synergistically to disability and mortality in older women. J Clin Endocrinol Metab 88:2019–2025

    Article  CAS  PubMed  Google Scholar 

  51. K/DOQI Practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003;42(4, S3):S7-S28

  52. Zofkovà I, Kancheva RL, Bendlovà B (1997) Effect of 1,25(OH)2 vitamin D3 on circulating insulin-like growth factor-I and β2 microglobulin in patients with osteoporosis. Calcif Tissue Int 60:236–239

    Article  PubMed  Google Scholar 

  53. Jorde R, Waterloo K, Saleh F, Haug E, Svartberg J (2006) Neuropsychological function in relation to serum parathyroid hormone and serum 25-hydroxyvitamin D levels. The Tromso study. J Neurol 253(4):464–470

    Article  CAS  PubMed  Google Scholar 

  54. Miya K, Morimoto S, Fukuo K, Imanaka S, Shiraishi T, Yamamato H, Kitano S, Miyashita Y, Inoue T (1991) Hirotani J. Nippon Ronen Igakkai Zasshi 28(1):34–39

    CAS  PubMed  Google Scholar 

  55. Przybelski RJ, Binkley NC (2007) Is vitamin D important for preserving cognition? A positive correlation of serum 25-hydroxyvitamin D concentration with cognitive function. Arch Biochem Biophys 460(2):202–205

    Article  CAS  PubMed  Google Scholar 

  56. Burne TH, McGrath JJ, Eyles DW, Mackay-Sim A (2005) Behavioural characterization of vitamin D receptor knockout mice. Behav Brain Res 157(2):299–308

    Article  CAS  PubMed  Google Scholar 

  57. Wiese RJ, Uhland-Smith A, Ross TK, Prahl JM, DeLuca HF (1992) Up-regulation of the vitamin D receptor in response to 1,25-dihydroxyvitamin D3 results from ligand-induced stabilization. J Biol Chem 267:20082–20086

    CAS  PubMed  Google Scholar 

  58. Francis RM, Peacock M, Barkworth SA (1984) Renal impairment and its effects on calcium metabolism in elderly women. Age Ageing 13:14–20

    Article  CAS  PubMed  Google Scholar 

  59. Nguyen TV, Eisman JA, Kelly PJ, Sambrook PN (1996) Risk factors for osteoporotic fractures in elderly men. Am J Epidemiol 144:255–263

    CAS  PubMed  Google Scholar 

Download references

Acknowledgement

We are indebted to Manfred Klasser, auditor and GWD consult, for his precise and meticulous monitoring.

Conflicts of interest

This study was supported by TEVA Pharmaceuticals Industries Ltd., Israel.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to L. Dukas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dukas, L., Schacht, E. & Runge, M. Independent from muscle power and balance performance, a creatinine clearance below 65 ml/min is a significant and independent risk factor for falls and fall-related fractures in elderly men and women diagnosed with osteoporosis. Osteoporos Int 21, 1237–1245 (2010). https://doi.org/10.1007/s00198-009-1064-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-009-1064-1

Keywords

Navigation